Skip to search formSkip to main contentSkip to account menu

POLYETHYLENE GLYCOL 3350 17000 MG Powder for Oral Solution [Miralax]

Known as: MiraLAX 17 GM Powder for Oral Solution, POLYETHYLENE GLYCOL 3350 17 g in 17 g ORAL POWDER, FOR SOLUTION [MiraLAX] 
National Institutes of Health

Related topics

Related topics

4 relations
MiralaxPOLYETHYLENE GLYCOL 3350Powder for Oral Solution

Broader (1)

POLYETHYLENE GLYCOL 3350 17000 MG Powder for Oral Solution

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Novel Colonoscopy Preparation of Organic Coconut Water With Miralax® and Dulcolax® in Split Doses for Decompensated Cirrhotics. A Randomized, Double-Blinded, Open-Labelled, Clinical Pilot Single…
2011
2011
Increased Risk of Severe Hyponatremia with Miralax-Gatorade vs Standard Bowel Preparation: 1525
2010
2010
A Randomized Blinded Prospective Trial Comparing PEG 3350 (MiraLAX®) with Bisacodyl Pretreatment versus PEG 3350 (MiraLAX®) with Lubiprostone Pretreatment versus PEG 3350 (MiraLAX®) without…
Review
2009
Review
2009
PEDIATRIC PHARMACOTHERAPY A Monthly Newsletter for Health Care Professionals from the University of Virginia Children ’ s Hospital Volume 15 Number 2 February 2009 Use of Ursodiol in Infants and…
rsodiol was approved by the Food and Drug Administration (FDA) in 1987 for the prevention and treatment of gallstones and for the… 
2009
2009
Off-label Use of Polyethylene Glycol 3350 (Miralax®) Compared with Polyethylene Glycol-Electrolyte Lavage Solution (PEG-ELS): Tolerability Trumps Potency: 496